Stay updated on Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.

Latest updates to the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page
- Check4 days agoChange DetectedA sitewide NIH notice about its terminology transition appears above the page, and the displayed site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site revision identifier changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the usual study details and navigation. This indicates the page is currently inaccessible due to access restrictions.SummaryDifference18%

- Check39 days agoChange DetectedThe page's revision label changed from v3.6.6 to v3.7.0, indicating a software update to the page.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a minor behind-the-scenes update. No substantive study content appears to be changed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.6.5 is now shown on the page, replacing v3.6.4. This reflects an updated build of the page without changing study content or navigation.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.